-
1.
公开(公告)号:US20100047184A1
公开(公告)日:2010-02-25
申请号:US12605558
申请日:2009-10-26
CPC分类号: A61K9/0007
摘要: A pharmaceutical composition in the form of effervescent tablets comprising an active ingredient and an effervescent blend, comprising an acidic component and sodium glycine carbonate as alkaline components. Preferred acid components are fumaric acid, maleic acid, and their salts. Tablets are prepared in normal thermohygrometric conditions and with standard tabletting equipment. A pre-granulation process is also disclosed.
摘要翻译: 泡腾片形式的药物组合物,其包含活性成分和泡腾混合物,其包含酸性组分和作为碱性组分的甘氨酸钠。 优选的酸组分是富马酸,马来酸及其盐。 在正常的温湿度条件和标准压片设备中制备片剂。 还公开了预制粒工艺。
-
公开(公告)号:US06667056B2
公开(公告)日:2003-12-23
申请号:US09932097
申请日:2001-08-20
IPC分类号: A61K946
CPC分类号: A61K9/0007
摘要: A pharmaceutical formulation in the form of a fast dissolving tablet comprising an active ingredient, sodium glycine carbonate and an acid capable of reacting rapidly with sodium glycine carbonate to release carbon dioxide.
-
3.
公开(公告)号:US06284272B1
公开(公告)日:2001-09-04
申请号:US09463224
申请日:2000-03-21
IPC分类号: A61K946
CPC分类号: A61K9/0007
摘要: A pharmaceutical composition in the form of effervescent tablets comprising an active ingredient and an effervescent blend, wherein the effervescent blend comprises an acidic component and sodium glycine carbonate as alkaline components. Preferred acid components are fumaric acid, maleic acid, and their salts. Tablets are prepared in normal thermo-hygrometric conditions and with standard tabletting equipment.
摘要翻译: 泡腾片剂形式的药物组合物,其包含活性成分和泡腾混合物,其中所述泡腾混合物包含作为碱性组分的酸性组分和甘氨酸钠。 优选的酸组分是富马酸,马来酸及其盐。 在正常的热湿度条件和标准压片设备中制备片剂。
-
-